Entrada Therapeutics Inc (TRDA) Insider Trading
- $923,397.49
- $5,751,716.13
- July 9, 2025
- Dipal Doshi
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 2, 2022 | Major Shareholder | 2,643 | $5.82 | Buy | $15,382.26 | |
| May 23, 2022 | Major Shareholder | 7,837 | $5.99 | Buy | $46,943.63 | |
| May 20, 2022 | Major Shareholder | 16,849 | $5.84 | Buy | $98,398.16 | |
| May 18, 2022 | Major Shareholder | 34,433 | $6.00 | Buy | $206,598.00 | |
| May 16, 2022 | Major Shareholder | 19,000 | $5.83 | Buy | $110,770.00 | |
| Jan. 12, 2022 | Director | 5,000 | $9.71 | Buy | $48,550.00 |
Insiders are both buying and selling Entrada Therapeutics Inc stock.
The insider traders at Entrada Therapeutics Inc are: Dipal Doshi, Kory James Wentworth, Nathan J Dowden, Natarajan Sethuraman, Nerissa Kreher, Peter S Kim, Bros. Advisors Lp Baker, Ventures V L.P. 5Am, Kush Parmar, John F Crowley, and Bioventures 2018 L.P. Mpm
The most active insider trader at Entrada Therapeutics Inc is Dipal Doshi with 32 trades.
Kory James Wentworth has sold the most Entrada Therapeutics Inc stock with a total value of $1,181,807.12.
Bros. Advisors Lp Baker has bought the most Entrada Therapeutics Inc stock with a total value of $969,149.33.
The most recent insider trade for Entrada Therapeutics Inc was on July 9, 2025.
The single biggest insider buy for Entrada Therapeutics Inc was from Bros. Advisors Lp Baker with a total value of $245,528.64 on June 6, 2022.
The single biggest insider sell for Entrada Therapeutics Inc was from Kush Parmar with a total value of $518,250.00 on June 27, 2025.